<bill session="107" type="h" number="4014" updated="2013-07-14T18:58:22-04:00">
  <state datetime="2002-11-06">ENACTED:SIGNED</state>
  <status>
    <unknown datetime="2002-11-06"/>
  </status>
  <introduced datetime="2002-03-20"/>
  <titles>
    <title as="introduced" type="short">Rare Diseases Orphan Product Development Act of 2002</title>
    <title as="passed house" type="short">Rare Diseases Orphan Product Development Act of 2002</title>
    <title as="enacted" type="short">Rare Diseases Orphan Product Development Act of 2002</title>
    <title as="introduced" type="official">To amend the Federal Food, Drug, and Cosmetic Act with respect to the development of products for rare diseases.</title>
  </titles>
  <sponsor id="400136"/>
  <cosponsors>
    <cosponsor id="400525" joined="2002-07-09"/>
    <cosponsor id="400527" joined="2002-04-24"/>
    <cosponsor id="400050" joined="2002-03-20"/>
    <cosponsor id="400062" joined="2002-04-09"/>
    <cosponsor id="400067" joined="2002-06-19"/>
    <cosponsor id="400522" joined="2002-06-11"/>
    <cosponsor id="400098" joined="2002-09-04"/>
    <cosponsor id="400101" joined="2002-04-10"/>
    <cosponsor id="400103" joined="2002-04-16"/>
    <cosponsor id="400106" joined="2002-06-17"/>
    <cosponsor id="400110" joined="2002-03-20"/>
    <cosponsor id="400122" joined="2002-07-09"/>
    <cosponsor id="400140" joined="2002-04-09"/>
    <cosponsor id="400160" joined="2002-04-09"/>
    <cosponsor id="400161" joined="2002-03-20"/>
    <cosponsor id="400166" joined="2002-07-09"/>
    <cosponsor id="400181" joined="2002-04-16"/>
    <cosponsor id="400506" joined="2002-04-09"/>
    <cosponsor id="400194" joined="2002-05-09"/>
    <cosponsor id="400202" joined="2002-07-09"/>
    <cosponsor id="400205" joined="2002-04-23"/>
    <cosponsor id="400213" joined="2002-04-16"/>
    <cosponsor id="400215" joined="2002-06-04"/>
    <cosponsor id="400218" joined="2002-04-23"/>
    <cosponsor id="400219" joined="2002-03-20"/>
    <cosponsor id="400231" joined="2002-04-16"/>
    <cosponsor id="400246" joined="2002-05-21"/>
    <cosponsor id="400247" joined="2002-04-25"/>
    <cosponsor id="400249" joined="2002-04-09"/>
    <cosponsor id="400262" joined="2002-04-18"/>
    <cosponsor id="400263" joined="2002-04-09"/>
    <cosponsor id="400513" joined="2002-04-09"/>
    <cosponsor id="400278" joined="2002-04-09"/>
    <cosponsor id="400554" joined="2002-04-16"/>
    <cosponsor id="400524" joined="2002-04-09"/>
    <cosponsor id="400295" joined="2002-04-24"/>
    <cosponsor id="400308" joined="2002-04-09"/>
    <cosponsor id="400321" joined="2002-04-18"/>
    <cosponsor id="400326" joined="2002-06-11"/>
    <cosponsor id="400528" joined="2002-04-09"/>
    <cosponsor id="400533" joined="2002-03-20"/>
    <cosponsor id="400350" joined="2002-03-20"/>
    <cosponsor id="400357" joined="2002-06-19"/>
    <cosponsor id="400539" joined="2002-07-15"/>
    <cosponsor id="400360" joined="2002-06-04"/>
    <cosponsor id="400373" joined="2002-03-20"/>
    <cosponsor id="400378" joined="2002-04-18"/>
    <cosponsor id="400380" joined="2002-04-09"/>
    <cosponsor id="400391" joined="2002-04-16"/>
    <cosponsor id="400409" joined="2002-04-09"/>
    <cosponsor id="400416" joined="2002-04-23"/>
    <cosponsor id="400424" joined="2002-06-25"/>
    <cosponsor id="400425" joined="2002-03-20"/>
    <cosponsor id="400427" joined="2002-04-16"/>
    <cosponsor id="400430" joined="2002-04-24"/>
    <cosponsor id="400435" joined="2002-06-11"/>
    <cosponsor id="400436" joined="2002-04-18"/>
    <cosponsor id="400438" joined="2002-04-09"/>
  </cosponsors>
  <actions>
    <action state="REFERRED" datetime="2002-03-20">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2002-03-26">
      <text>Referred to the Subcommittee on Health.</text>
      <committee name="House Committee on Energy and Commerce"/>
    </action>
    <action datetime="2002-09-05">
      <text>Committee Consideration and Mark-up Session Held.</text>
      <committee name="House Committee on Energy and Commerce"/>
    </action>
    <calendar state="REPORTED" datetime="2002-09-05">
      <text>Ordered to be Reported by Unanimous Consent.</text>
      <committee name="House Committee on Energy and Commerce"/>
    </calendar>
    <action datetime="2002-10-01T13:18:00-04:00">
      <text>Reported by the Committee on Energy and Commerce. H. Rept. 107-702.</text>
    </action>
    <calendar datetime="2002-10-01T13:19:00-04:00" calendar="Union" number="435">
      <text>Placed on the Union Calendar, Calendar No. 435.</text>
    </calendar>
    <action datetime="2002-10-01T13:29:00-04:00">
      <text>Mr. Shimkus moved to suspend the rules and pass the bill.</text>
    </action>
    <action datetime="2002-10-01T13:29:00-04:00">
      <text>Considered under suspension of the rules.</text>
      <reference ref="CR H6815-6818" label="consideration"/>
    </action>
    <action datetime="2002-10-01T13:29:00-04:00">
      <text>DEBATE - The House proceeded with forty minutes of debate ob H.R. 4014.</text>
    </action>
    <action datetime="2002-10-01T13:48:00-04:00">
      <text>At the conclusion of debate, the chair put the question on the motion to suspend the rules. Mr. Waxman objected to the vote on the grounds that a quorum was not present. Further proceedings on the motion were postponed. The point of no quorum was withdrawn.</text>
    </action>
    <action datetime="2002-10-01T18:47:00-04:00">
      <text>Considered as unfinished business.</text>
      <reference ref="CR H6883" label="consideration"/>
    </action>
    <vote state="PASS_OVER:HOUSE" datetime="2002-10-01T18:47:00-04:00" how="by voice vote" result="pass" type="vote" where="h">
      <text>On motion to suspend the rules and pass the bill Agreed to by voice vote.</text>
      <reference ref="CR H6815" label="text"/>
    </vote>
    <action datetime="2002-10-01T18:47:00-04:00">
      <text>Motion to reconsider laid on the table Agreed to without objection.</text>
    </action>
    <action datetime="2002-10-02">
      <text>Received in the Senate, read twice.</text>
    </action>
    <vote state="PASSED:BILL" datetime="2002-10-17" how="by Unanimous Consent" result="pass" type="vote2" where="s">
      <text>Passed Senate without amendment by Unanimous Consent.</text>
      <reference ref="CR S10769" label="consideration"/>
    </vote>
    <topresident datetime="2002-10-17">
      <text>Cleared for White House.</text>
    </topresident>
    <action datetime="2002-10-18">
      <text>Message on Senate action sent to the House.</text>
    </action>
    <topresident datetime="2002-10-28">
      <text>Presented to President.</text>
    </topresident>
    <signed datetime="2002-11-06">
      <text>Signed by President.</text>
    </signed>
    <enacted state="ENACTED:SIGNED" datetime="2002-11-06" type="public" number="107-281">
      <text>Became Public Law No: 107-281.</text>
    </enacted>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" activity="Referral, Markup, Reporting"/>
    <committee activity="Referral" code="HSIF14" subcommittee="Health" name="House Energy and Commerce"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Agriculture and food"/>
    <term name="Authorization"/>
    <term name="Department of Health and Human Services"/>
    <term name="Diet"/>
    <term name="Diseases"/>
    <term name="Economics and public finance"/>
    <term name="Federal aid to medical research"/>
    <term name="Government operations and politics"/>
    <term name="Medical supplies"/>
    <term name="Orphan drugs"/>
    <term name="Pharmaceutical research"/>
    <term name="Research grants"/>
    <term name="Science, technology, communications"/>
  </subjects>
  <amendments/>
  <summary>10/1/2002--Passed House without amendment.
Rare Diseases Orphan Product Development Act of 2002 - Amends the Orphan Drug Act to authorize appropriations for FY 2002 through 2006 for grants and contracts for the development of drugs for rare diseases and conditions.</summary>
</bill>
